♟️ Tuesday 19 August 2025 Tue, 19 Aug 2025

Challenger Limited reported a 9% increase in normalised net profit after tax for FY25, driven by strong Life business cash earnings and resilient Funds Management performance despite net outflows. The company also announced an 11% dividend increase and provided positive FY26 EPS guidance amid ongoing regulatory reforms.

Challenger Limited reported a solid 9% rise in normalised NPAT to $456 million for FY25, alongside an 11% dividend increase to 29.5 cents per share, underscoring its strategic momentum and capital strength. The company’s outlook for FY26 remains positive, with guidance pointing to continued growth and shareholder returns amid evolving retirement income reforms.

Monadelphous Group Limited reported a robust FY25 with $2.27 billion revenue and $158 million net profit, underpinned by strong contract wins and growth in energy and resources sectors.

Challenger Limited reported a robust FY25 with a 9% rise in normalised profit and a strategic push into digital transformation and retirement income solutions.

Challenger Limited celebrates four decades with a robust 9% rise in net profit and a strategic digital transformation, positioning itself at the forefront of Australia’s retirement income market.

Sims Limited reported a 4.1% increase in sales revenue to A$7.494 billion for FY25, alongside a 48.1% jump in underlying EBITDA to A$430 million. Despite a statutory net loss, the company declared a fully franked final dividend of 13 cents per share, reflecting confidence amid market challenges and portfolio reshaping.

HUB24 Limited reported robust FY25 results with revenue climbing 24% to $406.6 million and underlying net profit after tax soaring 44%. The company’s platform funds under administration grew 34%, underpinning a 47% increase in fully franked dividends.

CSL Limited reported solid FY25 financials with 5% revenue growth and announced a strategic transformation including a $500 million annual cost saving target and plans to spin off its vaccine business, CSL Seqirus, as a separate ASX-listed entity.

CSL Limited reported robust FY25 results alongside a sweeping strategic overhaul, including a major cost-saving program and plans to spin off its vaccine unit CSL Seqirus as a standalone ASX-listed company.

CSL Limited posted a 14% rise in net profit for FY2025, underpinned by strong immunoglobulin sales and new product launches, while announcing plans to demerge its vaccines business, CSL Seqirus, to sharpen strategic focus.

Mercury NZ Limited reported a 10% decline in earnings for FY2025 amid challenging generation conditions but is pressing ahead with significant renewable energy investments and raised dividends.

HMC Capital reported a robust FY25 with a 51% rise in operating EPS and a 47% jump in assets under management to $18.7 billion, driven by expansion across multiple funds management divisions.

Judo Bank reported a robust 24% increase in statutory net profit after tax for FY25, driven by strong loan book growth and operational efficiencies. The bank projects even stronger profit growth in FY26, underpinned by strategic expansion and technology upgrades.

HMC Capital has reported a record FY25 with pre-tax operating earnings soaring 74% and EPS up 51%, driven by strong asset growth and diversified platform success. The company sets a confident FY26 outlook targeting sustained organic growth and stable dividends.

Judo Capital Holdings Limited reported a robust FY25 with a 16% loan book expansion and a 14% rise in underlying profit before tax, underpinned by operational leverage and strategic regional growth.

HMC Capital Limited reported a record FY25 profit of $265.2 million, driven by strategic acquisitions and growth in digital infrastructure and energy transition sectors. The company also declared a consistent dividend and strengthened its balance sheet with an increased undrawn debt facility.